114 related articles for article (PubMed ID: 12970451)
1. Preinfection treatment of resistant mice with CpG oligodeoxynucleotides renders them susceptible to friend retrovirus-induced leukemia.
Olbrich AR; Schimmer S; Dittmer U
J Virol; 2003 Oct; 77(19):10658-62. PubMed ID: 12970451
[TBL] [Abstract][Full Text] [Related]
2. Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs.
Olbrich AR; Schimmer S; Heeg K; Schepers K; Schumacher TN; Dittmer U
J Virol; 2002 Nov; 76(22):11397-404. PubMed ID: 12388700
[TBL] [Abstract][Full Text] [Related]
3. Effective treatment of retrovirus-induced suppression of antibody responses with CpG oligodeoxynucleotides.
Kraft ARM; Arndt T; Hasenkrug KJ; Dittmer U
J Gen Virol; 2005 Dec; 86(Pt 12):3365-3368. PubMed ID: 16298983
[TBL] [Abstract][Full Text] [Related]
4. CpG oligodeoxynucleotides allow for effective adoptive T-cell therapy in chronic retroviral infection.
Kraft AR; Krux F; Schimmer S; Ohlen C; Greenberg PD; Dittmer U
Blood; 2007 Apr; 109(7):2982-4. PubMed ID: 17148590
[TBL] [Abstract][Full Text] [Related]
5. Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility.
Subramanian A; Hegde S; Correll PH; Paulson RF
Leuk Res; 2006 Sep; 30(9):1141-9. PubMed ID: 16527351
[TBL] [Abstract][Full Text] [Related]
6. Role of lymphoid cells in age-related change of susceptibility to Friend leukemia virus-induced leukemia.
Yamaguchi S; Kitagawa M; Inoue M; Tejima Y; Kimura M; Aizawa S; Utsuyama M; Hirokawa K
Mech Ageing Dev; 2001 Feb; 122(2):219-32. PubMed ID: 11166360
[TBL] [Abstract][Full Text] [Related]
7. Role of natural killer cells in resistance against friend retrovirus-induced leukemia.
Iwanami N; Niwa A; Yasutomi Y; Tabata N; Miyazawa M
J Virol; 2001 Apr; 75(7):3152-63. PubMed ID: 11238842
[TBL] [Abstract][Full Text] [Related]
8. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
9. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.
Weiner GJ; Liu HM; Wooldridge JE; Dahle CE; Krieg AM
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10833-7. PubMed ID: 9380720
[TBL] [Abstract][Full Text] [Related]
10. Screening of novel immunostimulatory CpG ODNs and their anti-leukemic effects as immunoadjuvants of tumor vaccines in murine acute lymphoblastic leukemia.
Wang J; Zhang W; He A; Zhao W; Cao X
Oncol Rep; 2011 Feb; 25(2):519-29. PubMed ID: 21165566
[TBL] [Abstract][Full Text] [Related]
11. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
Weiner GJ
J Leukoc Biol; 2000 Oct; 68(4):455-63. PubMed ID: 11037965
[TBL] [Abstract][Full Text] [Related]
12. Parameters of CpG oligodeoxynucleotide-induced protection against intravaginal HSV-2 challenge.
Sajic D; Ashkar AA; Patrick AJ; McCluskie MJ; Davis HL; Levine KL; Holl R; Rosenthal KL
J Med Virol; 2003 Dec; 71(4):561-8. PubMed ID: 14556270
[TBL] [Abstract][Full Text] [Related]
13. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
[TBL] [Abstract][Full Text] [Related]
14. Friend virus utilizes the BMP4-dependent stress erythropoiesis pathway to induce erythroleukemia.
Subramanian A; Hegde S; Porayette P; Yon M; Hankey P; Paulson RF
J Virol; 2008 Jan; 82(1):382-93. PubMed ID: 17942544
[TBL] [Abstract][Full Text] [Related]
15. [Study of antileukemic effect of CpG-oligodeoxynucleotides treated cord blood].
Chen CY; Jia JH; Pan XL; Zhou YB; Zhao WM
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):13-6. PubMed ID: 14990069
[TBL] [Abstract][Full Text] [Related]
16. CpG immunostimulatory sequences enhance contact hypersensitivity responses in mice.
Akiba H; Satoh M; Iwatsuki K; Kaiserlian D; Nicolas JF; Kaneko F
J Invest Dermatol; 2004 Sep; 123(3):488-93. PubMed ID: 15304088
[TBL] [Abstract][Full Text] [Related]
17. [Effects of morphine on murine infection with Friend retrovirus].
Rouveix B; Veyries ML
Bull Acad Natl Med; 1995 May; 179(5):1069-80. PubMed ID: 7583459
[TBL] [Abstract][Full Text] [Related]
18. CpG oligonucleotides: novel regulators of osteoclast differentiation.
Zou W; Schwartz H; Endres S; Hartmann G; Bar-Shavit Z
FASEB J; 2002 Mar; 16(3):274-82. PubMed ID: 11874977
[TBL] [Abstract][Full Text] [Related]
19. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
Gekeler V; Gimmnich P; Hofmann HP; Grebe C; Römmele M; Leja A; Baudler M; Benimetskaya L; Gonser B; Pieles U; Maier T; Wagner T; Sanders K; Beck JF; Hanauer G; Stein CA
Oligonucleotides; 2006; 16(1):83-93. PubMed ID: 16584297
[TBL] [Abstract][Full Text] [Related]
20. CpG-ODN Class C Mediated Immunostimulation in Rabbit Model of Trypanosoma evansi Infection.
Kumar P; Kumar R; Manuja BK; Singha H; Sharma A; Virmani N; Yadav SC; Manuja A
PLoS One; 2015; 10(6):e0127437. PubMed ID: 26039713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
